Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ALHC | Common Stock | Sale | -$32.5K | -5.31K | -0.74% | $6.11 | 713K | Mar 29, 2023 | Direct | F1, F2 |
transaction | ALHC | Common Stock | Sale | -$20.6K | -3.29K | -0.46% | $6.26 | 709K | Mar 31, 2023 | Direct | F3, F4 |
holding | ALHC | Common Stock | 519K | Mar 29, 2023 | See Footnote | F5 |
Id | Content |
---|---|
F1 | Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person. |
F2 | The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $6.02 to $6.25. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. |
F3 | Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock. This transaction does not represent a discretionary trade by the reporting person. |
F4 | The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $6.211 to $6.33. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. |
F5 | Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary. |